MyMitochondria — teal mitochondrion icon and my Mitochondria wordmarkScience & Health Powering Your CellsFind a Clinic
Latest edition · Mitochondrial medicine, translated without the hype
Research snapshot · Nov 11, 2026
Follow us on Google
NMN gummies hit shelves after the FDA reversal — nMN gummy supplements beside regulatory
Watchdog Claims review

NMN gummies hit shelves after the FDA reversal — while a meta-analysis finds no metabolic benefit

Edited by Samael A. Tejada, Founder & Editor-in-Chief

·

Vitafusion launched Vital NMN gummies on September 16, 2026, riding the wave of the FDA's late-2025 NMN reversal — the regulatory shift that reopened the US market for nicotinamide mononucleotide supplements. The timing is commercial; the science is not cooperating.

What does the 2026 meta-analysis say?

A systematic review in Nutrients pooled 15 randomized controlled trials (383 participants) and found NMN safe but with no significant effects on body weight, fasting glucose or lipids — and only a modest, non-significant trend on insulin resistance. Those are precisely the metabolic outcomes NMN marketing leans on.

But doesn't NMN raise NAD+?

Yes — NMN reliably raises NAD+ levels, and that much is established. The gap is between the biomarker and the benefit: raising NAD+ has not translated into measured metabolic or anti-aging outcomes in humans.

How does this connect to mitochondrial health?

NAD+ is central to mitochondrial energy metabolism, which is why NAD+ boosters are sold on mitochondrial promises. The meta-analysis is a reminder that a molecule's mitochondrial plausibility is not the same as a demonstrated mitochondrial benefit in people.

Where the evidence stands

Join the discussion

To get the conversation started: What questions does this story raise for you? Share them below — every comment is reviewed by our moderators before it appears.

Community discussion only — not medical advice. Every comment is reviewed by our moderators before it appears. Sign in with Google or a free Hyvor account to join in.

Follow MyMitochondria on Google

Site imagery: custom illustrations by MyMitochondria; stock photography via Pexels, Splitshire, StockCake and Vecteezy — illustrative only. Models pictured are not patients, clinicians, endorsers, or cases described in our articles.